Ginkgo Bioworks Holdings (DNA) Stock Price, Quote, News & History

Ginkgo Bioworks Holdings Inc (DNA) Stock Price, Quote, News & History

DNANYSE

Trade with Public

$6.68

0.233.57%

At close: Apr 10, 5:00 PM EST

$6.77

0.324.96%

Pre-Market: 4:00 AM EST

Key Statistics

Open

$6.68

Volume / Avg.

4.79K / 1.15M

Day Range

- - -

52 Wk Range

5.37 - 17.58

Market Cap

$410.20M

P/E Ratio

Dividend Yield

Exchange

NYSE

RSI

Short Interest

12.99%

Days to Cover

5.17

Recent Ginkgo Bioworks Holdings Inc News

Elon Musk Endorses 'Fundable' Jurassic Park: These De-Extinction Companies Are Already Making It Happen

Elon Musk tweeted about wanting Jurassic Park in real life. Companies aren't bringing back dinosaurs yet, but they are bringing extinct items back to life.

Chris Katje

Ginkgo Bioworks Pivots To AI And Robotics After Rough Quarter

Ginkgo Bioworks stock drops after earnings miss, lower sales, and shift to autonomous labs and robotics focus.

Vandana Singh

Ginkgo Bioworks (DNA) Shares Rise On New Cancer Screening Approach Plans

Ginkgo Bioworks shares are trading higher Monday afternoon, up over 8%, following the announcement of a strategic partnership with Carnegie Mellon University.

Henry Khederian

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-171.06M

Investing Cash Flow (TTM)

-240.29M

Financing Cash Flow (TTM)

17.77M

Free Cash Flow (TTM)

-178.72M

Capital Expenditure (TTM)

-7.67M

Net Change in Cash (TTM)

-393.57M

Analyst Trends and Forecast

Jan

Mar

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

2.1

Sell

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$430.92M

PE Ratio (TTM)

PE Ratio (FWD)

PEG Ratio (TTM)

PS Ratio (TTM)

2.18

PB Ratio (TTM)

0.81

Earnings Yield % (TTM)

-84.43%

Earnings Yield % (FWD)

EV / EBITDA (TTM)

Price / EBITDA (TTM)

Price / Free Cash Flow (TTM)

Book Value / Share

$8.21

Company Debt

Total Debt

LT Debt

LT Debt Issuance (TTM)

LT Debt Repayment (TTM)

-$354.00K

Total Cash

$167.20M

Debt to Equity

0.86

Issuance of Debt (TTM)

-$354.00K

Repayment of Debt (TTM)

-$354.00K

Key Statistics

Open

$6.68

Volume / Avg.

4.79K / 1.15M

Day Range

- - -

52 Wk Range

5.37 - 17.58

Market Cap

$410.20M

P/E Ratio

Dividend Yield

Exchange

NYSE

RSI

Short Interest

12.99%

Days to Cover

5.17

About

Sector

Health Care

Industry

Life Sciences Tools & Services

Ginkgo Bioworks Holdings Inc is the platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemic...

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Ginkgo Bioworks Holdings (DNA) stock?

You can purchase shares of Ginkgo Bioworks Holdings (NYSE:DNA) through any online brokerage.

View our list of the best stock brokerages

Who are Ginkgo Bioworks Holdings (DNA) competitors?

Other companies in Ginkgo Bioworks Holdings’s space includes: Codexis Inc (NASDAQ:CDXS), BioLife Solutions Inc (NASDAQ:BLFS), Lifecore Biomedical Inc (NASDAQ:LFCR), Quanterix Corp (NASDAQ:QTRX) and AbCellera Biologics Inc (NASDAQ:ABCL).

What is the forecast, or price target, for Ginkgo Bioworks Holdings (DNA) stock?

Ginkgo Bioworks Holdings has a consensus price target of $3.97.

What is the current price for Ginkgo Bioworks Holdings (DNA)?

The stock price for Ginkgo Bioworks Holdings (NYSE: DNA) is $6.77 last updated April 14, 2026 at 4:10 AM EDT.

Does Ginkgo Bioworks Holdings (DNA) pay a dividend?

There are no upcoming dividends for Ginkgo Bioworks Holdings.

When is Ginkgo Bioworks Holdings (NYSE:DNA) reporting earnings?

Ginkgo Bioworks Holdings does not have any upcoming earnings scheduled.

Is Ginkgo Bioworks Holdings (DNA) going to split?

There is no upcoming split for Ginkgo Bioworks Holdings.

What sector and industry does Ginkgo Bioworks Holdings (DNA) operate in?

Ginkgo Bioworks Holdings is in the Health Care sector and Life Sciences Tools & Services industry. They are listed on the NYSE.

People Also Watch

BioLife Solutions Inc

NASDAQ:BLFS

$20.11

Lifecore Biomedical Inc

AbCellera Biologics Inc

NASDAQ:ABCL

$3.74

2.14%

Cytek Biosciences Inc

Key Statistics

Open

$6.68

Volume / Avg.

4.79K / 1.15M

Day Range

- - -

52 Wk Range

5.37 - 17.58

Market Cap

$410.20M

P/E Ratio

Dividend Yield

Exchange

NYSE

RSI

Short Interest

12.99%

Days to Cover

5.17

Recent Ginkgo Bioworks Holdings Inc News

Elon Musk Endorses 'Fundable' Jurassic Park: These De-Extinction Companies Are Already Making It Happen

Elon Musk tweeted about wanting Jurassic Park in real life. Companies aren't bringing back dinosaurs yet, but they are bringing extinct items back to life.

Chris Katje

Ginkgo Bioworks Pivots To AI And Robotics After Rough Quarter

Ginkgo Bioworks stock drops after earnings miss, lower sales, and shift to autonomous labs and robotics focus.

Vandana Singh

Ginkgo Bioworks (DNA) Shares Rise On New Cancer Screening Approach Plans

Ginkgo Bioworks shares are trading higher Monday afternoon, up over 8%, following the announcement of a strategic partnership with Carnegie Mellon University.

Henry Khederian

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-171.06M

Investing Cash Flow (TTM)

-240.29M

Financing Cash Flow (TTM)

17.77M

Free Cash Flow (TTM)

-178.72M

Capital Expenditure (TTM)

-7.67M

Net Change in Cash (TTM)

-393.57M

Analyst Trends and Forecast

Jan

Mar

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

2.1

Sell

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$430.92M

PE Ratio (TTM)

PE Ratio (FWD)

PEG Ratio (TTM)

PS Ratio (TTM)

2.18

PB Ratio (TTM)

0.81

Earnings Yield % (TTM)

-84.43%

Earnings Yield % (FWD)

EV / EBITDA (TTM)

Price / EBITDA (TTM)

Price / Free Cash Flow (TTM)

Book Value / Share

$8.21

Company Debt

Total Debt

LT Debt

LT Debt Issuance (TTM)

LT Debt Repayment (TTM)

-$354.00K

Total Cash

$167.20M

Debt to Equity

0.86

Issuance of Debt (TTM)

-$354.00K

Repayment of Debt (TTM)

-$354.00K

Key Statistics

Open

$6.68

Volume / Avg.

4.79K / 1.15M

Day Range

- - -

52 Wk Range

5.37 - 17.58

Market Cap

$410.20M

P/E Ratio

Dividend Yield

Exchange

NYSE

RSI

Short Interest

12.99%

Days to Cover

5.17

About

Sector

Health Care

Industry

Life Sciences Tools & Services

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry